Medical Oncology

TTFields

Questions discussed in this category

Is it reasonable to extrapolate data from Glioblastoma and discuss Tumor Treating Fields in patients with Grade 4, IDH Mutant, astrocytomas?

2 Answers available

Papers discussed in this category

JAMA, 2017-12-19

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.

Frontiers in oncology, 2020 Jul 28

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma.

Oncology letters, 2019 Nov 19

Complete radiological response following subtotal resection in three glioblastoma patients under treatment with Tumor Treating Fields.

Annals of translational medicine, 2021 Dec

Case report: tumor-treating fields prolongs IDH-mutant anaplastic astrocytoma progression-free survival and pathological evolution to glioblastoma.

Related Topics in Medical Oncology